Essex Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-4,101
Closed -$280K – 641
2024
Q2
$280K Hold
4,101
– – 0.02% 500
2024
Q1
$278K Hold
4,101
– – 0.03% 437
2023
Q4
$253K Hold
4,101
– – 0.03% 434
2023
Q3
$242K Hold
4,101
– – 0.03% 412
2023
Q2
$245K Hold
4,101
– – 0.03% 404
2023
Q1
$240K Hold
4,101
– – 0.03% 429
2022
Q4
$254K Hold
4,101
– – 0.03% 405
2022
Q3
$232K Hold
4,101
– – 0.03% 400
2022
Q2
$262K Hold
4,101
– – 0.03% 389
2022
Q1
$266K Buy
4,101
+801
+24% +$50.8K 0.03% 412
2021
Q4
$220K Hold
3,300
– – 0.02% 455
2021
Q3
$201K Hold
3,300
– – 0.02% 447
2021
Q2
$204K Buy
+3,300
New +$201K 0.03% 434
2018
Q2
– Sell
-4,200
Closed -$207K – 310
2018
Q1
$207K Buy
+4,200
New +$216K 0.04% 327
2016
Q2
– Sell
-4,890
Closed -$223K – 311
2016
Q1
$223K Hold
4,890
– – 0.06% 269
2015
Q4
$264K Hold
4,890
– – 0.06% 250
2015
Q3
$241K Buy
4,890
+1,020
+26% +$58.5K 0.06% 270
2015
Q2
$226K Hold
3,870
– – 0.06% 288
2015
Q1
$222K Sell
3,870
-1,422
-27% -$77.8K 0.06% 286
2014
Q4
$267K Hold
5,292
– – 0.07% 247
2014
Q3
$248K Hold
5,292
– – 0.07% 246
2014
Q2
$238K Hold
5,292
– – 0.07% 259
2014
Q1
$223K Hold
5,292
– – 0.07% 253
2013
Q4
$208K Buy
+5,292
New +$199K 0.07% 259

Other funds holding IHE

Essex Financial Services's IHE Position: Q3 2024 in Review

Essex Financial Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2024, closing a stake of 4,101 shares — an estimated $280K sold.

Essex Financial Services first reported a position in IHE in Q4 2013 and held it in 24 quarters. The position peaked at $280K in Q2 2024. 143 funds tracked by Wall St. Rank hold IHE as of Q3 2024.

  • Essex Financial Services reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2024 after selling out during the quarter.
  • Essex Financial Services sold 4,101 iShares US Pharmaceuticals ETF shares in Q3 2024, an estimated $280K.
  • Essex Financial Services first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 24 quarters.
  • Essex Financial Services's iShares US Pharmaceuticals ETF position peaked at $280K in Q2 2024.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2024.

Based on Essex Financial Services's 13F filing for Q3 2024, filed 24 Oct 2024.